Lymphedema Treatment Market Skyrocketing Revenue Growth of US$ 11.58 billion to Hit Stunning CAGR of 5.1% during 2021-2028

Lymphedema is a condition in which the body enlarges abnormally due to the lymphostasis caused by lymphatic system dysfunction. It most commonly affects the lower extremity (90%), upper extremity (10%), and genitalia (1%). Primary lymphedema is present at birth whereas secondary lymphedema is caused by lymphatic system inefficiency or damage. The secondary lymphedema frequently develops after cancer treatment.

The Lymphedema Treatment Market is projected to reach US$ 11.58 billion by 2028 from US$ 8.15 billion in 2021; it is expected to grow at a CAGR of 5.1% from 2021 to 2028.

Lymphedema Treatment Market report by "The Insight Partners" sheds light on the key drivers and opportunities attributing to market expansion over the analysis period. It also gives in-depth information pertaining to the challenges and threats poised to hinder revenue generation in the forthcoming years. Additionally, the report also provides crucial information regarding leading companies in this business sphere and the trends that are likely to prevail in the near future.

Get Sample PDF Copy of Lymphedema Treatment Market at:
https://www.theinsightpartners.com/sample/TIPRE00026594/?utm_source=OpenPR&utm_medium=10411

List of Companies operating in this report are:
• BIOCOMPRESSION SYSTEMS
• Tactile Medical
• Smith & Nephew
• BSN medical GmbH
• Lohmann & Rauscher GmbH & Co. KG
• SIGVARIS GROUP
• ThermoTek
• Huntleigh Healthcare Limited
• 3M
• Mego Afek ltd

Furthermore, the market is segmented based on type, application, and region in order to study it exhaustively and provide the data in a systematic manner. Speaking of competitive landscape, the study includes a list of leading companies along with their product and service offerings, strategic decisions, SWOT analysis, latest developments, market share captured, growth rate, and valuation. The challenges faced by these companies are analyzed and solutions for them are given as well.

Market Insights
Rising Cases of Lymphedema
According to the United States Department of Health and Human Services, lymphedema can occur in cancer patients upon the onset of the disease or after its treatment, which affect lymph node drainage. For example, it has been reported that it can occur within days and up to 30 years after the treatment for breast cancer. Also, 80% of patients experience onset within 3 years of surgery, and the remainder develops edema at a rate of 1% per year. Additionally, a large patient pool, particularly women, suffers from lower-limb lymphedema after the treatment of gynecologic cancer, with the highest prevalence (37%) among vulvar cancer survivors and lowest prevalence (7%) among ovarian cancer survivors. Further, the overall incidence of arm lymphedema ranges from 8% to 56% at two years post-surgery. The Alliance Z 1071 longitudinal substudy of the American College of Surgeons Oncology Group (ACOSOG) states that in breast cancer trials, patients report a 3-year cumulative incidence of arm swelling and arm heaviness.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Lymphedema Treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

Have Question? Speak to Analyst at:
https://www.theinsightpartners.com/speak-to-analyst/TIPRE00026594/?utm_source=OpenPR&utm_medium=10411

Several market forces such as drivers and restraints and political, social, economic and technological advancements help shape up the industry in specific manner. All such forces are studied in detail to arrive at a market forecast which can help build the investment strategies in Lymphedema Treatment market.

Essential points covered in Lymphedema Treatment market report are:-
1 What will the market size and the growth rate be in 2028?
2 What are the key growth stimulants of Lymphedema Treatment market?
3 What are the key market trends impacting Lymphedema Treatment market valuation?
4 What are the challenges to market proliferation?
5 Who are the key vendors in the Lymphedema Treatment market?
6 Which are the leading companies contributing to Lymphedema Treatment market valuation?
7 What was the market share held by each region in 2028?
8 What is the estimated growth rate and valuation of Lymphedema Treatment market in 2028?

Order a Copy of Lymphedema Treatment Market Share, Strategies and Forecasts 2021-2028 Research Report at:
https://www.theinsightpartners.com/buy/TIPRE00026594/?utm_source=OpenPR&utm_medium=10411

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.